FDA's Guidance on Artificial Intelligence Devices
FDA expects manufacturers to commit to transparency and real-world performance monitoring, to periodically update FDA on changes implemented as part of the approved pre-specifications and algorithm change protocol and follow Good Machine Learning Practice guiding principles
United Kingdom Ai Software Health Canada Regulatory Agency Drug Administration Device Software Functions Draft Guidance
Source: natlawreview.com